Table 1 Data on drop-out, adherence, and adverse events during the 12-week intervention period (N = 92)a,b
All | HP-diet and β-cryptoxanthin | HP-diet | β-Cryptoxanthin | Control | p valuec | |
|---|---|---|---|---|---|---|
Drop-out (discontinuing the intervention) | 6 (6.5) | 1 (4.3) | 2 (8.7) | 2 (8.7) | 1 (4.3) | 1.000 |
Adherence (taking ≥ 90% of prescribed capsules) | 84 (91.3) | 22 (95.7) | 20 (87.0) | 21 (91.3) | 21 (91.3) | 0.956 |
Adverse events (reporting gastrointestinal discomfort or headache) | 16 (17.4) | 5 (21.7) | 5 (21.7) | 3 (13.0) | 3 (13.0) | 0.803 |